1Price KR, Fenwick GR. Naturally occurring oestrogens in foods – a review. Food Addit. Contam. 1985; 2: 73–106.
2Knight DC, Eden J. Phytoestrogens – a short review. Maturitas 1995; 22: 167–75.
3Mazur W. Phytoestrogen content in foods. Ballières Clin. Endocrin. Metab. 1998; 12: 729–42.
4Mazur W, Fotsis T, Wahala K, Ojala S, Salakka A, Adlercreutz H. Isotope dilution gas chromatographic–mass spectrometric method for the determination of isoflavonoids, coumestrol, and lignans in food samples. Anal. Biochem. 1996; 233: 169–80
5Mazur W, Wahala K, Rasku S, Salakka A, Hase T, Adlercreutz H. Lignan and isoflavonoid concentrations in tea and coffee. Br. J. Nutr. 1998; 79: 37–45.
6Mazur W, Duke JA, Wahala K, Rasku S, Adlercreutz H. Isoflavonoids and lignans in legumes: nutritional and health aspects in humans. J. Nutr. Biochem. 1998; 9: 193–200.
7Horn-Ross PL, Lee M, John EM, Koo J. Sources of phytoestrogen exposure among non-Asian women in California, USA. Cancer Causes Control 2000; 11: 299–302.
8De Kleijn MJJ, van der Schouw YT, Wilson PWF, Adlercreutz H, Mazur W, Grobbee DE, et al. Intake of dietary phytoestrogens is low in postmenopausal women in the United States: the Framingham study (1–4). J. Nutr. 2001; 131: 1826–32.
9Keinan Boker L, van der Schouw YT, de Kleijn MJJ, Jacques PF, Grobbee DE, Peeters PHM. Intake of dietary phytoestrogens in Dutch women. J. Nutr. 2002; 132: 1319–28.
10Van Erp Baart AMJ, Brants HAM, Kiely M, Mulligan A, Turrini A, Sermineta C, et al. Isoflavone intakes in different European countries: the VENUS approach [abstract]. Ann. Nutr. Metab. 2001; 45: 219.
11Chen Z, Zheng W, Custer LJ, Dai Q, Shu XO, Jin F, et al. Usual dietary consumption of soy foods and its correlation with the excretion rate of isoflavonoids in overnight urine samples among Chinese women in Shanghai. Nutr. Cancer 1999; 33: 82–7.
12Adlercreutz H. Western diet and Western diseases: some hormonal and biochemical mechanisms and associations. Scand. J. Clin. Lab. Invest. 1990; 50(Suppl. 201): 3–23.
13Adlercreutz H, Mazur W. Phyto-oestrogens and Western diseases. Ann. Med. 1997; 29: 95–120.
14Bingham SA, Atkinson C, Liggins J, Bluck L, Coward A. Phyto-oestrogens: where are we now? Br. J. Nutr. 1998; 79: 393–406.
15Setchell KD. Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr. 1998; 68(Suppl.): 1333S–46S.
16Anderson JW, Johnstone BM, Cook-Newell ME. Meta-analysis of the effects of soy protein intake on serum lipids. N. Engl. J. Med. 1995; 333: 276–82.
17Van der Schouw YT, de Kleijn MJ, Peeters PH, Grobbee DE. Phyto-oestrogens and, cardiovascular disease risk. Nutr. Metab. Cardiovasc. Dis. 2000; 10: 154–67.
18Alekel DL, StGermain A , Peterson CT, Hanson KB, Stewart JW, Toda T. Isoflavone-rich soy protein isolate attenuates bone loss in the lumbar spine of perimenopausal women. Am. J. Clin. Nutr. 2000; 72: 844–52.
19Horiuchi T, Onouchi T, Takahashi M, Ito H, Orimo H. Effect of soy protein on bone metabolism in postmenopausal Japanese women. Osteoporosis Int. 2000; 11: 721–4.
20Wangen KE, Duncan AM, Merz-Demlow BE, Xu X, Marcus R, Phipps WR, et al. Effect of soy isoflavones on markers of bone turnover in premenopausal and postmenopausal women. J. Clin. Endocrinol. Metab. 2000; 85: 3043–8.
21Kronenberg F. Hot flashes. In: Lobo RA, ed. Treatment of the Postmenopausal Woman. New York: Raven Press, 1994; 97–116.
22Messina M, Persky V, Setchell KD, Barnes S. Soy intake and cancer risk: a review of the in vitro and in vivo data. Nutr. Cancer 1994; 21: 113–31.
23Peeters PHM, Keinan Boker L, van de Schouw YT, Grobbee DE. Phytoestrogens and breast cancer risk. Review of the epidemiological evidence. Breast Cancer Treat. Res. 2002; in press.
24Rose DP, Boyar AP, Wynder EL. International comparisons of mortality rates for cancer of the breast, ovary, prostate and colon, and per capita food consumption. Cancer 1986; 58: 2363–71.
25Riboli E. Nutrition and cancer: background and rationale of the European Prospective Investigation into Cancer and Nutrition (EPIC). Ann. Oncol. 1992; 3: 783–91.
26Riboli E, Hunt KJ, Slimani N, Ferrari P, Norat T, Fahey M, et al. European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collection. Public Health Nutr. 2002; 5(6B): 1113–24.
27Plummer M, Clayton D, Kaaks R. Calibration in multi-centre cohort studies. Int. J. Epidemiol. 1994; 23: 419–26.
28Kaaks R, Plummer M, Riboli E, Estee J, van Staveren WA. Adjustment for bias due to errors in exposure assessments in multi-center cohort studies on diet and cancer: a calibration approach. Am. J. Clin. Nutr. 1994; 59(Suppl.): S245–50.
29Kaaks R, Riboli E, van Staveren WA. Calibration of dietary intake measurements in prospective cohort studies. Am. J. Epidemiol. 1995; 142: 548–56.
30Kaaks R, Riboli E. Validation and calibration of dietary intake in measurements in the EPIC project. Int. J. Epidemiol. 1997; 26(Suppl. 1): S15–25.
31Slimani N, Kaaks R, Ferrari P, Casagrande C, Clavel-Chapelon F, Lotze G, et al. European Prospective Investigation into Cancer and Nutrition (EPIC) calibration study: rationale, design and population characteristics. Public Health Nutr. 2002; 5(6B): 1125–45.
32Slimani N, Deharveng G, Charrondière UR, van Kappel AL, Ocké MC, Welch A, et al. Structure of the standardized computerized 24-hour diet recall interview used as reference method in 22 centres participating in the EPIC project. Comput. Meth. Programs Biomed. 1999; 53: 251–66.
33Voss S, Charrondière UR, Slimani N, Kroke A, Riboli E, Wahrendorf J, et al. EPIC-SOFT a European computer program for 24-hour-dietrary protocols [in German]. Z. Ernahrungswiss. 1998; 37: 227–33.
34Slimani N, Ferrari P, Ocké M, Welch A, Boeing H, Liere M, et al. Standardisation of the 24-hour diet recall calibration method used in the European Prospective Investigation into Cancer and Nutrition (EPIC): general concepts and preliminary results. Eur. J. Clin. Nutr. 2000; 54: 900–17.
35SPSS, Inc. Statistical Package for the Social Sciences, Version 9.0. Chicago, IL: SPSS, Inc., 1998.
36Wakai K, Egami I, Kato K, Kawamura T, Tamakoshi A, Lin A, et al. Dietary intake and sources of isoflavones among Japanese. Nutr. Cancer 1999; 33: 139–45.
37Kim J, Kwon C. Estimated dietary isoflavone intake in Korean population based on National Nutrition Survey. Nutr. Res. 2001; 21: 947–53.
39Shu XO, Jin F, Dai Q, Wen W, Potter JD, Kushi LH, et al. Soyfood intake during adolescence and subsequent risk of breast cancer among Chinese women. Cancer Epidemiol. Biomark. Prev. 2001; 10: 483–8.
40Ho SC, Woo JL, Leung SS, Sham AL, Lam TH, Janus ED. Intake of soy products is associated with better plasma lipid profiles in the Hong Kong Chinese population. J. Nutr. 2000; 130: 2590–3.
41Strom SS, Yamamura Y, Duphrone CM, Spitz MR, Babaian RJ, Pillow PC, et al. Phytoestrogen intake and prostate cancer: a case control study using a new database. Nutr. Cancer 1999; 33: 20–5.
42Goodman-Gruen D, Kritz-Silverstein D. Usual dietary, isoflavone intake is associated with cardiovascular disease risk factors in postmenopausal women. J. Nutr. 2001; 13: 1202–6.
43Bookwalter GN. Soy protein utilization in food systems. Adv. Exp. Med. Biol. 1978; 105: 749–66.
44Vidal C, Perez-Carral C, Chomon B. Unsuspected sources of soybean exposure. Ann. Allergy Asthma Immunol. 1997; 79: 350–2.
45Meyer R, Chardonnens F, Hubner P, Luthy J. Polymerase chain reaction (PCR) in the quality and safety assurance of food: detection of soya in processed meat products. Z. Lebensm. Unters. Forsch. 1996; 203: 339–44.
46Verkasalo PK, Appleby PN, Allen NE, Davey G, Adlercreutz H, Key TJ. Soya intake and plasma concentrations of daidzein and genistein: validity of dietary assessment among eighty British women (Oxford arm of the European Prospective Investigation into Cancer and Nutrition). Br. J. Nutr. 2001; 86: 1–8.
47Key TJ, Davey GK, Appleby PN. Health benefits of a vegetarian diet. Proc. Nutr. Soc. 1999; 58: 271–5.
48Janelle KC, Bart SI. Nutrient intakes, and eating behavior scores of vegetarian and nonvegetarian women. J. Am. Diet. Assoc. 1995; 95: 180–6.
49Appleby PN, Thorogood M, Mann JI, Key TJA. The Oxford vegetarian study: an overview. Am. J. Clin. Nutr. 1999; 70(Suppl.): 525S–31S.
50Haddad EH, Berk LS, Kettering JD, Hubbard RW, Peters WR. Dietary intake and biochemical, hematologic and immune status of vegans compared with nonvegetarians. Am. J. Clin. Nutr. 1999; 70(Suppl.): 586S–93S.